Selenium and Antioxidant Composition for Osteoarthritis Cartilage Protection

Solution Overview

Problem

Current treatments for osteoarthritis primarily focus on pain relief and lack effective measures for regenerating cartilage or modulating degeneration, with selenium's therapeutic potential in osteoarthritis remaining unclear and unexplored.

Innovation Solution

A pharmaceutical composition and health functional food combining selenium-containing materials like selenite, selenate, or selenomethionine with antioxidants such as N-acetylcysteine, ascorbic acid, or glutathione to inhibit cartilage degeneration by reducing oxidative stress, thereby preventing or treating osteoarthritis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If current drug treatments (anti-inflammatory drugs or chondroprotective agents) are used, then pain relief is achieved, but cartilage regeneration and degeneration modulation remain ineffective

Engineering Contradiction:
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent combines selenium-containing materials with antioxidants (such as N-acetylcysteine, ascorbic acid, or glutathione) to create a composite therapeutic composition. This composite approach addresses both oxidative stress and inflammation simultaneously, enabling both pain relief and cartilage regeneration effects that single-agent treatments cannot achieve alone.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent introduces selenium-containing materials as a new therapeutic parameter/ingredient that has not been previously explored in osteoarthritis treatment. By adding this new parameter (selenium) to the treatment regimen, the patent expands the therapeutic capabilities beyond traditional anti-inflammatory and chondroprotective agents, enabling both symptom relief and disease modification.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If selenium-containing materials alone are used, then antioxidant function is provided, but therapeutic effectiveness for osteoarthritis remains unclear

Engineering Contradiction:
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The patent merges selenium-containing materials with specific antioxidants in defined combinations and ratios. This merging creates a synergistic effect where the combination provides both the antioxidant function of selenium and the enhanced protective effects of the co-administered antioxidants, thereby confirming therapeutic effectiveness for osteoarthritis that neither component achieves alone.

Inventive Principle:
Principle #5Merging (Combining)

3Ease of operation

If anti-inflammatory drugs are used for pain relief, then symptomatic treatment is achieved, but underlying cartilage degeneration is not addressed

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent creates a multi-functional therapeutic composition that simultaneously provides pain relief (anti-inflammatory effect), oxidative stress reduction (antioxidant effect), and cartilage protection/regeneration (chondroprotective effect). This single composition performs multiple therapeutic functions that traditionally required separate medications, addressing both symptoms and underlying pathology.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination of selenium and antioxidants effectively reduces oxidative stress, inhibiting cartilage degeneration and the progression of osteoarthritis, offering a novel therapeutic approach for prevention and treatment.

Implementation Method 1

The pharmaceutical composition or health functional food including a selenium-containing material and an antioxidant according to the present invention can inhibit degeneration of cartilage by a mechanism including reducing oxidative stress in cells constituting the cartilage.

Methodology Applied
Scientific EffectOxidative stress reduction: Oxidation

Data Source

PatentUS20240382518A1Pharmaceutical composition and health functional food for prevention or treatment of osteoarthritis
Publication Date: 2024.11.21
  • US20240382518A1 patent drawing
  • US20240382518A1 patent drawing
  • US20240382518A1 patent drawing

AI summary

A composition according to an embodiment includes a selenium-containing material and an antioxidant. The composition may inhibit degeneration of cartilage by a mechanism such as reducing oxidative stress in cells constituting the cartilage. Accordingly, it is possible to inhibit an occurrence of osteoarthritis, delay its progression, or enable treatment of osteoarthritis.